Farhi acquires Westmount Mall with plans for apartments on site
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
CTV News
18 hours ago
- CTV News
Hours away from Air Canada flights being grounded
As flight attendants get set to strike, only a last-minute deal will keep Air Canada flying. CTV's Kimberley Fowler reports.
Globe and Mail
21 hours ago
- Globe and Mail
CleanTech Announces Grant of Stock Options
Vancouver, British Columbia--(Newsfile Corp. - August 15, 2025) - CleanTech Vanadium Mining Corp. (TSXV: CTV) (OTCQB: CTVFF) (FSE: C9R) (" CleanTech" or the " Company") announces that its board of directors has approved the grant of incentive stock options (the "Options") to certain directors, officers, employees and consultants to acquire a total of 875,000 common shares in the capital of the Company at an exercise price of $0.06. All Options were granted pursuant to the Company's 10% rolling stock option plan (the "Plan") and are subject to the terms of the Plan, the applicable grant agreements and the requirements of the TSX-V. The Options are exercisable for a five-year term expiring August 14, 2030. The Options will vest at 12.5% per quarter for the first two years following the grant date. About CleanTech Vanadium Mining Corp. CleanTech is a mining company focused on critical mineral resources in the USA. The Company has an option to acquire 7,180 acres of mineral rights with historic Fluorspar resources across multiple projects in Illinois-Kentucky Fluorspar district. CleanTech also owns a 100% interest in the Gibellini Vanadium Mine Project in Nevada. Further information on CleanTech can be found at Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Globe and Mail
a day ago
- Globe and Mail
Smith & Nephew (SN) Receives a Hold from Stifel Nicolaus
Stifel Nicolaus analyst Dylan Van Haaften maintained a Hold rating on Smith & Nephew today and set a price target of £14.15. The company's shares closed today at p1,353.00. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Van Haaften covers the Healthcare sector, focusing on stocks such as Merck KGaA, Smith & Nephew, and Sartorius. According to TipRanks, Van Haaften has an average return of -5.5% and a 32.65% success rate on recommended stocks. In addition to Stifel Nicolaus, Smith & Nephew also received a Hold from Berenberg Bank's Sam England in a report issued on August 11. However, yesterday, Bank of America Securities reiterated a Buy rating on Smith & Nephew (LSE: SN). SN market cap is currently £11.76B and has a P/E ratio of 30.99. Based on the recent corporate insider activity of 69 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of SN in relation to earlier this year.
